Jenny Jiao Selected Research

Ecraprost

5/2007	Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes.
4/2006	Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jenny Jiao Research Topics

Disease

9	Macular Edema 01/2021 - 06/2010
7	Retinal Vein Occlusion 01/2018 - 06/2010
2	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 10/2020
2	Cataract (Cataracts) 01/2018 - 12/2011
2	Peripheral Arterial Disease 12/2006 - 04/2006
1	Inflammation (Inflammations) 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Uveitis 01/2018
1	Hemorrhage 07/2013
1	Pain (Aches) 05/2007
1	Chronic Limb-Threatening Ischemia 05/2007
1	Ischemia 04/2006

Drug/Important Bio-Agent (IBA)

9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 06/2010
6	salicylhydroxamic acid (SHAM)IBA 01/2018 - 06/2010
3	Ranibizumab (Lucentis)FDA Link 01/2021 - 03/2017
2	Retinaldehyde (Retinal)IBA 01/2018 - 06/2016
2	Alprostadil (Muse)FDA LinkGeneric 05/2007 - 04/2006
2	EcraprostIBA 05/2007 - 04/2006
1	Phosphodiesterase InhibitorsIBA 12/2006
1	4- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochlorideIBA 12/2006
1	ProdrugsIBA 04/2006
1	LipidsIBA 04/2006
1	ProstaglandinsIBA 04/2006
1	EicosanoidsIBA 04/2006

Therapy/Procedure

2	Injections 01/2018 - 12/2011
2	Therapeutics 05/2007 - 04/2006
1	Light Coagulation 01/2021
1	Lasers (Laser) 01/2021
1	Surgical Amputation (Amputations) 05/2007